These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 6820163

  • 1. Von Willebrand's disease.
    Zimmerman TS, Ruggeri ZM.
    Prog Hemost Thromb; 1982; 6():203-36. PubMed ID: 6820163
    [No Abstract] [Full Text] [Related]

  • 2. Transplantation of normal bone marrow into a pig with severe von Willebrand's disease.
    Bowie EJ, Solberg LA, Fass DN, Johnson CM, Knutson GJ, Stewart ML, Zoecklein LJ.
    J Clin Invest; 1986 Jul; 78(1):26-30. PubMed ID: 3088043
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The varieties of von Willebrand's disease.
    Tuddenham EG.
    Clin Lab Haematol; 1984 Jul; 6(4):307-23. PubMed ID: 6441672
    [No Abstract] [Full Text] [Related]

  • 5. Rationale for the treatment of von Willebrand's disease.
    Sultan Y.
    Prog Clin Biol Res; 1981 Jul; 72():149-62. PubMed ID: 6801684
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Von Willebrand's disease.
    Hoyer LW.
    Prog Hemost Thromb; 1976 Jul; 3():231-87. PubMed ID: 781732
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diagnostic problems of von Willebrand's disease in a general hospital laboratory.
    Dahl CJ, McRoyan DK, Liu PI.
    Ann Clin Lab Sci; 1983 Jul; 13(5):371-8. PubMed ID: 6416137
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effectiveness of D-arginine vasopressin in von Willebrand's disease.
    Bala L, Boggio L, Green D.
    Curr Hematol Rep; 2005 Jan; 4(1):1-2. PubMed ID: 15610653
    [No Abstract] [Full Text] [Related]

  • 12. [Multimeric composition of factor VIII-related protein following DDAVP infusion in normal subjects and patients with hemophilia A and von Willebrand's disease].
    Takase T, Nishino M, Yasui M, Shima M, Yoshikawa N, Fukui H.
    Nihon Ketsueki Gakkai Zasshi; 1985 Nov; 48(7):1571-8. PubMed ID: 3937410
    [No Abstract] [Full Text] [Related]

  • 13. Properties of post-infusion factor VIII in von Willebrand's disease.
    Muntz RH, Ekert H, Helliger H.
    Thromb Res; 1974 Aug; 5(2):111-23. PubMed ID: 4547286
    [No Abstract] [Full Text] [Related]

  • 14. Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families.
    Mahasandana C, Suvatte V, Püng-amritt P, Tuchinda S.
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):243-7. PubMed ID: 316576
    [No Abstract] [Full Text] [Related]

  • 15. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ, Hoyer LW, Rickles FR, Varma A, Rogers J.
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [Abstract] [Full Text] [Related]

  • 16. Pseudo-von Willebrand's disease.
    Hoyer LW.
    N Engl J Med; 1982 Feb 11; 306(6):360-2. PubMed ID: 6798443
    [No Abstract] [Full Text] [Related]

  • 17. Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor.
    Ruggeri ZM, Lombardi R, Gatti L, Bader R, Valsecchi C, Zimmerman TS.
    Blood; 1982 Dec 11; 60(6):1453-6. PubMed ID: 6982737
    [Abstract] [Full Text] [Related]

  • 18. Immunologic studies in von Willebrand's disease: alteration of factor VIII/von Willebrand protein after transfusion with plasma concentrates in patients with von Willebrand's disease.
    Sultan Y, Simeon J, Maisonneuve P, Caen JP.
    Thromb Haemost; 1976 Feb 29; 35(1):110-9. PubMed ID: 1085498
    [Abstract] [Full Text] [Related]

  • 19. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma JP, Vicic WJ, Rogers J.
    N Engl J Med; 1982 Feb 11; 306(6):326-33. PubMed ID: 6798442
    [Abstract] [Full Text] [Related]

  • 20. [Physiopathology and therapy of hemophilia and von Willebrand's disease].
    Fukui H.
    Nihon Naika Gakkai Zasshi; 1991 Jun 10; 80(6):866-74. PubMed ID: 1919201
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.